DO YOU HAVE oGVHD?
We are looking for you! Keep exploring to learn more.
ABOUT THE STUDY
This clinical trial is designed to test the effectiveness of a new eye drop treatment called d-MAPPS for individuals suffering from chronic ocular graft-versus-host disease (oGVHD). Ocular GVHD is a condition that can occur after a bone marrow or stem cell transplant, where the donated cells attack the recipient's eyes, leading to dryness and discomfort.
By participating in this study, individuals with oGVHD can access a potential new treatment at no cost, receive regular monitoring and care from experienced eye care professionals, and be compensated for travel and time. This participation not only offers personal benefits but also contributes to medical research that may lead to improved treatments and better quality of life for those affected by oGVHD.
WHY PARTICIPATE
Clinical Trial Study Locations
Massachusetts Locations
​
Boston, Massachusetts, United States, 02215
​
Recruiting
Eyewell, LLC.
Contact: Kristen Brown, OD
(617) 433-9895 | Kristen.brown@myeyewell.com
​
California Locations
​
Huntington Beach, California, United States, 92648
Recruiting
Beach Eye Medical Group
Contact: Samir A Shah, MD, MS, FACS
(714) 965-9696 | drshah@beacheye.com
Kentucky Locations
​
Lexington, Kentucky, United States, 40517
Recruiting
Kentucky Eye Institute
Contact: Paul Karpecki, O.D.
859-278-9393 | karpecki@karpecki.com